The economic burden of immigrants with HIV/AIDS: When to say no?
by Peter C. Coyte, Kednapa Thavorn, Hana Dhanji
J. for Global Business Advancement (JGBA), Vol. 3, No. 1, 2010

Abstract: The Canadian Immigration and Refugee Protection Act (IRPA) of 2001 outlines the conditions under which individuals may be granted or denied admission to Canada. The Act stipulates that applications for residence will be rejected if an applicant's health is likely to generate excessive demand on Canadian health or social services. The purpose of this paper is to assess the thresholds used to define excessive demand and to apply these thresholds to persons with HIV/AIDS. Three findings are reported: firstly, the current threshold for excessive demand is too low and a statistically more appropriate threshold is three-fold greater; secondly, there is an inverse relationship between HIV/AIDS disease progression and healthcare costs and finally, comparison of disease cost estimates to new thresholds for inadmissibility allows classification to depend on individual characteristics, including age, sex and health status, and the time horizon over which each applicant's projected demand is assessed.

Online publication date: Tue, 20-Apr-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the J. for Global Business Advancement (JGBA):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com